2024
ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update
Imaging P, Niell B, Jochelson M, Amir T, Brown A, Adamson M, Baron P, Bennett D, Chetlen A, Dayaratna S, Freer P, Ivansco L, Klein K, Malak S, Mehta T, Moy L, Neal C, Newell M, Richman I, Schonberg M, Small W, Ulaner G, Slanetz P. ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update. Journal Of The American College Of Radiology 2024, 21: s126-s143. PMID: 38823941, DOI: 10.1016/j.jacr.2024.02.019.Peer-Reviewed Original ResearchConceptsReduce breast cancer mortalityRecommendation of mammographyBreast cancerBreast cancer mortalityBreast cancer riskBreast cancer screeningDigital breast tomosynthesisEvidence-based guidelinesAmerican College of Radiology Appropriateness CriteriaPeer-reviewed journalsMultidisciplinary expert panelRAND/UCLA Appropriateness Method User ManualMultiple different imaging modalitiesPeer-reviewed literatureScreening recommendationsCancer screeningCancer mortalityCancer riskGuideline developmentAppropriateness of imagingRecommendations AssessmentBreast tomosynthesisEstablished methodology principlesExpert panelAmerican College
2022
The role of lung cancer risk and comorbidity in lung cancer screening use
Richman IB, Long JB, Poghosyan H, Sather P, Gross CP. The role of lung cancer risk and comorbidity in lung cancer screening use. Preventive Medicine Reports 2022, 30: 102006. PMID: 36203942, PMCID: PMC9530957, DOI: 10.1016/j.pmedr.2022.102006.Peer-Reviewed Original ResearchLung cancer screeningLung cancer riskDiagnostic chest CTCancer riskLow comorbidityCancer screeningChest CTGreater lung cancer riskHigher lung cancer riskLow-dose computed tomographyCancer screening useLung cancer mortalityDose computed tomographyElectronic health recordsLCS useCohort studyPatient characteristicsEligible adultsCancer mortalityScreening useComorbiditiesComputed tomographyDiagnostic CTDiagnostic imagingPatients